montañana-rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 1 18 
 n e u r o s c e n c e 
 spinal inhibitory neuron degenerate motor 
 neuron excitatory neuron mouse 
 model als 
 Roser montañana-­ 
 rosell1 Raghavendra selvan1,2 pablo hernández-­ 
 varas3 Jan M. Kaminski1,2† 
 Simrandeep Kaur sidhu1 Dana B. ahlmark1 Ole kiehn1 ilary Allodi1,4 
 Amyotrophic lateral sclerosis als characterize progressive loss somatic motor neuron major fo- 
 cus direct motor neuron intrinsic property cause degeneration attention 
 give contribution spinal interneuron present work apply multiplexing detection 
 transcript machine learning base image analysis investigate fate multiple spinal interneuron pop- 
 ulation als progression sod1g93a mouse model analysis show spinal inhibitory inter- 
 neuron affect early disease motor neuron death characterize slow progressive 
 degeneration excitatory interneuron affect later steep progression report dif- 
 ferential vulnerability inhibitory excitatory subpopulation study reveal strong interneuron 
 involvement als development interneuron specific degeneration observation point differential 
 involvement diverse spinal neuronal circuit eventually determine motor neuron degeneration 
 introduction 
 amyotrophic lateral sclerosis als somatic motor neuron de- 
 generate lead muscle denervation wasting 1 
 people affect disease progressively lose ability control 
 muscle perform movement execution movement require 
 coordinate activation motor neuron pool appropriate mus- 
 cle activation 2 activation mediate complex network 
 inhibitory excitatory intraspinal neuron decode input 
 descending motor pathway afferent sensory input 
 3 ventral horn spinal cord inhibitory excit- 
 atory neuron divide cardinal class v0 v1 v2 
 v3 identify expression specific molecular marker 
 define cell fate development 4 research number 
 vertebrate specie show specific subpopulation inhibi- 
 tory spinal neuron express glycine γ-­ 
 aminobutyric acid 
 gaba excitatory spinal neuron express glutamate 
 acetylcholine form central pattern generator cpg control 
 rhythmic movement regulate coordination locomo- 
 tion 2 3 5 6 
 cardinal class diversify v0 interneu- 
 ron base axonal projection excitatory inhibi- 
 tory neurotransmitter divide class neuron 
 small group v0 neuron express pitx2 transcription factor 
 V0C/G subpopulation ipsilaterally projecting contain ei- 
 ther acetylcholine glutamate localized cen- 
 tral canal 7 cholinergic v0c neuron main source c 
 bouton 7 8) large population v0 interneuron con- 
 tralaterally projecting inhibitory v0d excitatory v0v 
 characterize expression lack thereof dbx1 evx1 
 transcription factor control left-­ 
 right alternation slow 
 v0d high speed v0v locomotion 9–11 v1 interneuron 
 large ipsilaterally project inhibitory population 
 adult mouse 80 glycinergic coexpress- 
 ing gaba 12 previous study show population 
 highly heterogeneous depend marker coexpression 
 50 subpopulation identify 13 14 mammal v1 
 interneuron know control speed locomotion 15 
 Renshaw cell rcs Ia interneuron belong v1 
 class 12 v2 interneuron ipsilaterally project 
 divide v2a excitatory interneuron v2b inhibitory inter- 
 neuron v2a neuron characterize expression tran- 
 scription factor chx10 16 rhythmically active 
 locomotion 17 v2b neuron identify gata2/3 expression 
 18 v1 interneuron require coor- 
 dination flexor-­ 
 extensor alternation 19 20 v3 interneu- 
 ron project contralaterally ipsilaterally 21 22 
 excitatory ablation silencing neuron lead change 
 left-­ 
 right coordination 21 molecularly define ex- 
 citatory population shox2 17 hb9-­ 
 positive 
 call mnx1 23 neuron shox2 neuron find inter- 
 mediate area spinal cord 75 coexpress Chx10 
 remain 25 shox2-­ 
 positive chx10-­ 
 negative 
 know involve rhythm generation 17 hb9 ex- 
 press motor neuron interneuron inter- 
 mediate area contribute locomotor rhythm 
 generation 23 
 growing evidence report spinal circuit dysregulation 
 als review 24 cholinergic c bouton motor neuron 
 undergo change als progression 25 glycinergic inter- 
 neuron change electrophysiological property early post- 
 natal p stage ventrally located neuron 
 excitable 26 recent finding show p45 be- 
 fore motor neuron degeneration muscle denervation 
 loss glycinergic synapsis fast motor neuron 27 include 
 1department Neuroscience University Copenhagen copenhagen Denmark 
 2department Computer Science University Copenhagen copenhagen 
 Denmark 3core Facility Integrated Microscopy University Copenhagen 
 Copenhagen Denmark 4school psychology Neuroscience University St 
 Andrews St Andrews UK 
 corresponding author email ole.​ 
 kiehn@​ 
 sund.​ 
 ku.​ 
 dk o.k. iallodi@​ 
 sund.​ 
 ku.​ 
 dk 
 ia51@​ 
 st-­ 
 andrews.​ 
 ac.​ 
 uk i.a. 
 †alexandra Instituttet a/s Rued Langgaards Vej 7 2300 copenhagen S Denmark 
 copyright © 2024 
 Authors right 
 reserved exclusive 
 licensee American 
 Association 
 Advancement 
 Science claim 
 original U.S. 
 Government Works 
 distribute 
 Creative Commons 
 Attribution 
 NonCommercial 
 License 4.0 cc by-­ 
 NC 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 2 18 
 v1 interneuron synapsis 27 study report 
 loss v1 v2a interneuron different disease stage 28 29 
 temporal dynamic potential loss excitatory 
 inhibitory interneuron ventral spinal cord motor related cir- 
 cuit disease development reveal 
 interneuron population essential movement set 
 perform study 
 clear challenge type investigation inherent dif- 
 ficultie able study fate multiple interneuron sub- 
 population disease progression succeed require 
 simultaneous visualization molecular marker spinal 
 cord disease develop previous study multiplexe 
 antibody staining different marker identify neuro- 
 nal subpopulation spinal cord 13 recent ad- 
 vancement multiplexing detection transcript allow 
 visualization ten hundred marker 
 time 30 31 multiplexe detection visualization 
 routinely perform laboratory 32–34 reliable quantifi- 
 cation multiple transcript cell prove difficult 
 require manual annotation present study 
 develop machine learning base tool automize cell segmenta- 
 tion subsequent transcript registration bioinformatic 
 analysis pipeline perform spatial analysis differentially express 
 transcript combination multiplexing detection 
 computational analysis allow investigate change expres- 
 sion molecular marker identify multiple class interneuron 
 spinal cord motor neuron population sod1g93a 
 mouse time point disease progression presymptomatic 
 disease stage p30 ii onset locomotor disease stage p63 iii 
 end disease stage motor neuron death p112 find inhibi- 
 tory subpopulation interneuron start lose specific marker 
 e.g. engrailed-­ 
 1 en1 calb1 early disease contrast 
 excitatory interneuron e.g. chx10-­ 
 positive lose specific mark- 
 er late stage disease change expression 
 appear quickly symptomatic stage result point to- 
 ward large contribution spinal interneuron circuit disease 
 distinct degenerative temporal dynamic inhibitory ex- 
 citatory interneuron 
 result 
 developmentally define neuronal marker maintain 
 adult spinal cord 
 expression molecularly define interneuron marker 
 mainly characterize mouse development embryonic 
 postnatal stage 4 13 marker transcription fac- 
 tor expression appear down-­ 
 regulate adult tis- 
 sue make antibody detection sensitive previously show 
 en1 transcript identify v1 interneuron reliably 
 detect mouse adult spinal cord   situ hybridization 27 
 35 present study compare expression 24 marker 
 Fig.   1 b p1 p28 mouse spinal cord tissue validate 
 presence spatial location adult   situ 
 sequencing technique cartana Fig.   2a replace xeni- 
 um 10x Genomics 31 technique allow detection 
 250 marker time barcode probe 
 detect specific transcript 31 sequencing information 
 spatial localization barcode provide x-­ 
 ​ 
 y coor- 
 dinate acquire tile image 31 allow exact lo- 
 calization transcript spinal cord Fig.   2a 
 exact subpopulation identification coexpression multiple marker 
 require outline neuronal soma cell body 
 need assign potential expression multiple marker 
 cell previous computational method develop 
 identify cell body boundary base segmentation nuclear 
 4′,6-­ 
 diamidino-­ 
 2-­ 
 phenylindole dapi staining 32 36 
 neuron find ventral dorsal area spinal cord 
 differ substantially shape size ventral neuron larg- 
 er dorsal neuron characterize small rounder 
 soma segmentation base nuclear staining 
 capture diverse cell body size spinal cord segment spinal 
 neuron implement machine learning deep ensem- 
 ble approach show Fig.   2a outline cell body 
 neurotrace provide fluorescent Nissl staining 
 cytoplasm neuron nucleus neurotrace image analyze 
 spinal cord tissue obtain   situ sequencing regis- 
 tere dapi image obtain cartana x-­ 
 ​ 
 y coordinate 
 registration Fig.   2a probabilistic segmentation cell body 
 b 
 
 Fig. 1 interneuronal marker investigate present study circuitry schematic locomotor circuit mammalian lumbar spinal cord 
 Shown cardinal ventral interneuron subpopulation v0d v0v v0c v1 v1 rcs v1 ia interneuron v2a v2b v3 shox2 hb9 interneuron 
 main ipsilateral solid contralateral dash projection inhibitory input show triangle excitatory show circle b panel marker de- 
 tecte study represent different interneuron population interest transcript expression underlined marker quantify characteriza- 
 tion interneuron dysregulation als progression 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 3 18 
 Fig. 2 fate-­ 
 defining marker present adult mouse tissue Pipeline processing analysis   situ sequencing datum neurotrace nt image 
 acquire register   situ sequencing datum base 4′,6-­ 
 diamidino-­ 
 2-­ 
 phenylindole dapi staining segmentation neuronal cell us- 
 ing machine learning deep ensemble model base use u-­ 
 net convolutional neural network k-­ 
 fold cross-­ 
 validation apply separately 
 patch 512 × 512 pixel annotate datum p1 52 annotate patch p28 20 annotate patch merge ensemble step obtain proba- 
 bilistic segmentation confidence threshold structural kernel apply obtain final segmentation   situ sequencing coordinate register 
 transcript localize segment cell final processing r coordinate normalize plot visualization qualitative 
 analysis b validation identity marker   situ sequencing technique wild-­ 
 type wt young adult mouse lumbar spinal cord p28 right compare early postna- 
 tal p1 leave interneuron population include study pitx2 pink circle V0C/G en1 blue square v1 chx10 green diamond v2a shox2 khaki tri- 
 angle choline acetyltransferase chat salmon circle v0c motor neuron c validation marker inhibitory interneuron subpopulation adult mouse 
 tissue include parvalbumin Pvalb blue circle calb1 green square foxp2 khaki diamond pou6f2 salmon triangle sp8 pink circle datum b c 
 pool n   =   2 section n   =   1 mouse p1 n   =   2 mouse p28 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 4 18 
 obtain basis neurotrace staining 
 updated version deep ensemble method previously develop 
 limited label training datum 37 neuron annotation p1 
 n   =   52 annotate patch n   =   2 section indepen- 
 dent mouse p28 tissue n   =   20 annotate patch n   =   2 sec- 
 tion independent mouse generate train 
 parallel model u-­ 
 net convolutional neural network cnn 
 k-­ 
 fold cross-­ 
 validation Fig.   2a final ensemble model ob- 
 taine combination p1 p28 model 
 probabilistic segmentation tile image threshold 0.4 con- 
 fidence structural kernel 5 apply define final 
 segmentation analysis neuron visualize yellow 
 green Fig.   2a transcript x-­ 
 ​ 
 y coordinate register 
 segment neuron spatial analysis perform hemi- 
 cord total n   =   6 p1 n   =   29 p28 spinal cord section 3 
 11 mouse respectively analyze validate transcript expres- 
 sion spatial localization cross section obtain lumbar l 
 segment 1 3 include study figure   2B show ex- 
 ample spatial analysis cardinal neuronal identity marker 
 pitx2 en1 chx10 shox2 choline acetyltransferase chat p1 
 versus p28 tissue graph include datum spinal cord sec- 
 tion mouse p1 section mouse p28 
 marker show different color shape example 
 spatial segregation marker inhibitory interneuron subpopula- 
 tion include parvalbumin Pvalb 12 Calbindin calb1 foxp2 
 pou6f2 sp8 13 combination en1 
 represent v1 interneuron show Fig.   2C example combi- 
 natorial expression interneuron marker show fig.   s1 
 b include colocalization inhibitory marker en1 
 lack representation marker p28 explain 
 fact   situ sequencing technique detect 30 tran- 
 script especially underrepresente lowly express 
 marker pitx2 combinatorial en1/sp8 portray 
 dataset 2 6 section 29 take account 
 dataset show facilitate visualization marker 
 detect 
 analysis demonstrate interneuron marker 
 embryonically early postnatally characterize 
 spinal interneuron population 4 38 39 find adult 
 spinal cord basis spatial localization appear 
 marker-­ 
 identify interneuron population maintain identity 
 adult spinal cord 
 interneuron marker sod1g93a mouse 
 single mrna molecule quantification healthy sod1g93a 
 tissue rnascope hiplexup technique acd Bio- 
 Techne Fig.   3 fig.   s2a rnascope know detect ~95 
 mrna molecule target transcript hiplexup 
 technique allow simultaneous detection 48 transcript 
 tissue 24 transcript originally investigate 
   situ sequencing Fig.   1b probe design vali- 
 date acd BioTechne procedure perform 
 show fig.   s2a series hybridization-­ 
 amplification 
 labeling cleave round series image ac- 
 quire total round probe image round 
 dapi neurotrace staining include image registration 
 cell segmentation respectively imagej registration ma- 
 trixe hiplexup round plus neurotrace gener- 
 ate basis dapi staining transform 
 merge 26 superimpose tile image spinal cord section 
 transcript + dapi + neurotrace fur- 
 ther processing ZEN software Zeiss machine learning– 
 base intellesis tool Zeiss cell segmentation 
 neuron enrichment fig.   s2 b c orange positive frac- 
 tion   =   neuron include study blue negative frac- 
 tion   =   background cell x-­ 
 ​ 
 y coordinate area 
 obtain segment neuron intensity mean 
 sd obtain transcript express neuron 
 fig.   s2b 
 different time point include study p30 pre- 
 symptomatic disease stage p63 onset-­ 
 of-­ 
 locomotor-­ 
 phenotype 
 disease stage p112 symptomatic disease stage motor 
 neuron death wild-­ 
 type wt sod1g93a mouse 
 include time point analysis perform hemicord 
 sod1g93a show asymmetrical loss neuron spi- 
 nal cord similar patient als spinal cord onset 40–43 
 leave right hemicord analyze mouse 
 hemisection include hemicord approach 
 98.943 neuron segment 84.791 include 
 study apply soma size threshold 70 μm2 
 compare number segment neuron condition 
 time point observe comparable number neuron 
 include study average 625 segment cell 
 hemisection multiple unpaired t test Welch correction p30 
 t   =   0.5782 df   =   38 p   >   0.9999 p63 t   =   1.311 df   =   41 p   =   0.5918 
 p112 t   =   0.09803 df   =   46 p   >   0.9999 n   =   20 26 hemisection 
 N   =   3 mouse condition fig.   s2d spatial distribution 
 segment neuron show individual mouse fig.   s2e 
 p112 change expression level visually notable 
 marker e.g. en1 chx10 clear decrease in- 
 tensity compare control condition Fig.   3 c f 24 
 marker investigate disease progression sod1g93a 
 mouse present work follow marker re- 
 late major class ventral interneuron discuss un- 
 derline Fig.   1b en1 foxp2 pou6f2 sp8 v1 interneuron 
 calb1 v1 putative rcs pvalb foxp2 v1 putative ia inter- 
 neuron chx10 v2a interneuron shox2 excitatory interneu- 
 ron pitx2 chat vglut2 v0c/g interneuron chat motor 
 neuron glyt2 gad67 gad65 vglut2 neurotransmitter-­ 
 define neuron 
 v1 inhibitory interneuron early dysregulation 
 differential vulnerability subpopulation 
 image postprocessing Fig.   4a fig.   s2 b v1 inter- 
 neuron define inhibitory neuron glyt2-­ 
 gad65-­ 
 and/ 
 gad67-­ 
 positive positive en1 Fig.   4 b c analysis per- 
 form presymptomatic disease stage alteration 
 en1 expression p30 nest unpaire two-­ 
 tailed t test t   =   1.305 
 df   =   10 p   =   0.2210 n   =   20 22 hemisection n   =   6 hemicord 
 mouse condition Fig.   4d previous datum 
 manual detection show ~25 decrease en1 transcript ex- 
 pression p63 sod1g93a mouse 27 find 
 similar decrease expression p63 automize ap- 
 proach p63 19.2 down-­ 
 regulation nest unpaire two-­ 
 tailed 
 t test t   =   2.493 df   =   10 p   =   0.0318 n   =   21 22 hemisection 
 N   =   6 hemicord mouse condition Fig.   4d en1 
 loss exacerbate symptomatic mouse total de- 
 crease 45.4 compare control p112 nest unpaire 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 5 18 
 Fig. 3 interneuron marker transcript detect rnascope hiplexup microscopy image obtain rnascope hiplexup multiplexe   situ hybridization wt 
 leave sod1g93a mouse right p112 include marker characterization interneuron dysregulation facilitate visualization marker divide 
 subset subset condition overview hemisection show inset high magnification b subset 1 include 
 neurotransmitter marker glyt2 blue gad67 orange gad65 deep red vglut2 green chat purple c d subset 2 include marker inhibitory v1 
 population en1 blue foxp2 orange pou6f2 yellow sp8 red calb1 green Pvalb purple arrow point neuron en1+/pou6f2 + yellow en1+/sp8 + 
 red en1+/calb1 + green putative renshaw cell en1+/foxp2+/pvalb+ purple orange stroke putative v1 ia interneuron e F subset 3 include mark- 
 er excitatory population chx10 green v2a shox2 purple pitx2 red V0C/G arrow point neuron chx10 + green shox2 + purple 
 Chx10+/Shox2 + white pitx2 + red 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 6 18 
 Fig. 4 v1 interneuron population dysregulate sod1g93a mouse analysis workflow b c image hiplexup assay show detection en1 
 blue nt gray control b sod1g93a c lumbar spinal cord p112 d significant reduction inhibitory glyt2 + gad67 + and/or gad65 + en1 + neuron 
 sod1g93a mouse red compare control gray p63 p112 nest unpaire two-­ 
 tailed t test p30 p   =   0.2210 p63 p   =   0.0318 p112 p   <   0.0001 e loss en1 + 
 neuron sod1g93a mouse right/red compare healthy control left/gray especially ventral-­ 
 region p112 datum pool p112 sec- 
 tion show individual cell black dot count-­ 
 base kernel density estimation dimension main panel x y dimension right 
 F k hiplexup image en1 blue colocalize v1 subpopulation marker orange foxp2 e f pou6f2 g h sp8 j nt gray 
 control sod1g93a mouse p112 l n quantification sod1g93a mouse versus control show significant decrease foxp2 + neuron p63 p112 l nest 
 unpaired two-­ 
 tailed t test p63 p   =   0.0036 p112 p   <   0.0001 pou6f2 + neuron p63 p112 m nest unpaire two-­ 
 tailed t test p63 p   =   0.0100 p112 p   =   0.0007 
 sp8 + neuron p112 n nest unpaire two-­ 
 tailed t test p63 p   =   0.7444 p112 p   =   0.0083 scale bar 100 μm 2d kernel density e plot 10 bin 
 viridis scale n   =   6 hemicord mouse fill shape represent biological replicate number hemisection shape technical replicate 
 biological replicate p30 n(wt   =   22 n(sod1   =   20 p63 n(wt   =   22 n(sod1   =   21 p112 n(wt   =   23 n(sod1   =   26 datum show mean   ±   sd 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 7 18 
 two-­ 
 tailed t test t   =   6.379 df   =   47 p   <   0.0001 n   =   23 26 hemi- 
 section n   =   6 hemicord mouse condition 
 evident visualization spatial distribution 
 count-­ 
 base kernel density estimation Fig.   4 b e 
 investigate potential differential vulnerability v1 
 subpopulation analyze FoxP2-­ 
 pou6f2-­ 
 sp8-­ 
 positive neu- 
 ron 13 p63 p112 time point Fig.   4 f n quantify 
 neuron positive glyt2 gad65 and/or gad67 en1 
 marker foxp2 pou6f2 sp8 Fig.   4 F k analysis 
 reveal differential vulnerability neuron foxp2 
 p63 37.4 down-­ 
 regulation nest unpaire two-­ 
 tailed t test 
 t   =   3.777 df   =   10 p   =   0.0036 n   =   22 21 hemisection n   =   6 hemi- 
 cord mouse condition Fig.   4l pou6f2-­ 
 positive 
 neuron p63 35.1 down-­ 
 regulation nest unpaire two-­ 
 tailed t 
 test t   =   3.168 df   =   10 p   =   0.0100 n   =   22 21 hemisection n   =   6 
 hemicord mouse condition Fig.   4 m decrease 
 number early time-­ 
 point compare sp8-­ 
 positive neuron 
 p63 ns nest unpaire two-­ 
 tailed t test t    =    0.328 df    =    41 
 p   =   0.7444 n   =   22 21 hemisection n   =   6 hemicord 
 mouse condition Fig.   4n despite appear initially resis- 
 tant sp8-­ 
 positive neuron reduce number p112 p112 
 36.4 down-­ 
 regulation nest unpaire two-­ 
 tailed t test t   =   2.754 
 df   =   47 p   =   0.0083 n   =   23 26 hemisection n   =   6 hemicord 
 mouse condition Fig.   4n time point foxp2-­ 
 
 pou6f2-­ 
 expressing neuron decrease number 
 p112 foxp2 44.3 down-­ 
 regulation nest unpaire two-­ 
 tailed t 
 test t   =   5.502 df   =   47 p   <   0.0001 p112 pou6f2 43.9 downregula- 
 tion nest unpaire two-­ 
 tailed t test t   =   3.637 df   =   47 p   =   0.0007 
 n   =   23 26 hemisection n   =   6 hemicord mouse 
 condition Fig.   4 l m spatial information change 
 expression p63 en1 transcript foxp2 pou6f2 
 sp8 show fig.   s3 d positive neuron include 
 analysis independently low high ex- 
 pression transcript show contour plot 
 display neuron cutoff spatial density 
 putative rcs ia interneuron member v1 subpopula- 
 tion analyze p63 p112 functionally define 
 interneuron population find specific area ventral spi- 
 nal cord 12 study putative ia interneuron identify 
 inhibitory interneuron glyt2 + gad65 + and/or gad67 + positive 
 en1 foxp2 Pvalb Fig.   5 b 12 re- 
 stricte location ventrolateral area spinal cord 
 Ia interneuron find Fig.   5D decrease number 
 inhibitory en1+/foxp2+/pvalb+ neuron find p63 42.0 
 down-­ 
 regulation p112 45.8 down-­ 
 regulation Fig.   5 
 c d p63 nest unpaire two-­ 
 tailed t test t   =   3.279 df   =   41 
 p   =   0.0021 n   =   22 21 hemisection n   =   6 hemicord 
 mouse condition p112 nest unpaire two-­ 
 tailed t test t   =   4.760 
 df   =   47 p   <   0.0001 n   =   23 26 hemisection n   =   6 hemicord 
 mouse condition putative rcs identify ex- 
 pression inhibitory marker glyt2 gad65 and/or gad67 
 combination en1 calb1 Fig.   5 e f ventral 
 location spinal cord Fig.   5h number ventral inhibi- 
 tory en1+/calb1 + neuron reduce 52.8 p63 p63 nest 
 unpaired two-­ 
 tailed t test t   =   2.587 df   =   10 p   =   0.0271 n   =   22 21 
 hemisection n   =   6 hemicord mouse condition 
 Fig.   5 g reduction exacerbate p112 79.5 de- 
 crease p112 nest unpaire two-­ 
 tailed t test t   =   3.630 df   =   10 
 p   =   0.0046 n   =   23 26 hemisection n   =   6 hemicord 
 mouse condition Fig.   5 g h spatial distribution 
 putative v1 ia rcs p63 show fig.   s4 b 
 datum analyze v1 subpopula- 
 tion affect symptomatic stage sod1g93a mouse 
 compare wt control early disease 
 v1 subpopulation differential vulnerability sp8 + neu- 
 ron resistant loss transcript putative rcs 
 strongly affect 
 inhibitory neurotransmitter expression v1 interneuron 
 survival decrease symptomatic stage en1 
 transcript lose early 
 expression glycine transporter 2 glyt2 enzyme 
 catalyze gaba neurotransmitter gad67 call gad1 
 gad65 call gad2 investigate time 
 point Fig.   6 figs.   s5 s6 marker visual- 
 ize glycinergic gaba-­ 
 releasing gabaergic neuron respec- 
 tively glyt2 transcript Fig.   6 b down-­ 
 regulate 
 p112 p30 nest unpaire two-­ 
 tailed t test t   =   0.332 df   =   10 
 p   =   0.7469 n   =   22 20 hemisection n   =   6 hemicord 
 mouse condition p63 nest unpaire two-­ 
 tailed t test t   =   0.881 
 df   =   41 p   =   0.3836 n   =   22 21 hemisection n   =   6 hemicord 
 mouse condition p112 nest unpaire two-­ 
 tailed t 
 test t   =   3.058 df   =   10 p   =   0.0121 n   =   23 26 hemisection n   =   6 
 hemicord mouse condition Fig.   6 c d gad67 
 expression Fig.   6 e f decrease p112 p30 
 nest unpaire two-­ 
 tailed t test t   =   0.105 df   =   40 p   =   0.9172 
 n   =   22 20 hemisection n   =   6 hemicord mouse 
 condition p63 nest unpaired-­ 
 tailed t test t   =   1.604 df   =   10 
 p   =   0.1398 n   =   22 21 hemisection n   =   6 hemicord 
 mouse condition p112 nest unpaire two-­ 
 tailed t test t   =   3.399 
 df   =   47 p   =   0.0014 n   =   23 26 hemisection n   =   6 hemicord 
 mouse condition Fig.   6 g h change 
 gad65 transcript level Fig.   6 j observe 
 investigate time point p30 nest unpaire two-­ 
 tailed t test 
 t   =   0.414 df   =   10 p   =   0.6879 n   =   22 20 hemisection n   =   6 hemi- 
 cord mouse condition p63 nest unpaire two-­ 
 tailed 
 t test t   =   1.273 df   =   41 p   =   0.2101 n   =   22 21 hemisection n   =   6 
 hemicord mouse condition p112 nest unpaire two-­ 
 tailed t test t   =   0.995 df   =   10 p   =   0.3431 n   =   23 26 hemisection 
 N   =   6 hemicord mouse condition Fig.   6 k l 
 investigate inhibitory interneuron survival per- 
 form lineage trace v1 subpopulation sod1g93a 
 mouse generate triple transgenic mouse carry 
 sod1g93a mutation express tdtomato 44 en1 pro- 
 moter sod1g93a;en1cre;r26rtdtomato mouse Fig.   7a tdtomato-­ 
 positive neuron quantify wt mouse different time point 
 compare p63 p84 p112 sod1g93a mouse Fig.   7 b 
 c quantification tdtomato-­ 
 positive neuron Fig.   7d 
 evaluate v1 interneuron fate quantification double-­ 
 positive tdtomato en1 neuron Fig.   7e evaluate 
 transcript fate v1 population quantification reveal 
 significant decrease number tdtomato+ cell symptomatic 
 mouse p112 compare wt mouse nest one-­ 
 way analysis vari- 
 ance anova Dunnett post hoc f3,28 = 3.332 wt control 
 group n   =   65 hemisection n   =   14 hemicord 7 mouse sod1 
 p63 p   =   0.4608 n   =   26 hemisection n   =   6 hemicord 
 mouse sod1 p84 p   =   0.6398 n   =   25 hemisection n   =   6 hemicord 
 mouse sod1 p112 p   =   0.0115 n   =   27 hemisection n   =   6 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 8 18 
 hemicord mouse Fig.   7d analysis transcript fate 
 v1 population show decrease expression en1 
 p63 maintain p84 decrease p112 
 nest one-­ 
 way anova Dunnett post hoc f3,28 = 38.24 wt 
 control group n   =   65 hemisection n   =   14 hemicord 7 mouse 
 sod1 p63 p   <   0.0001 n   =   26 hemisection n   =   6 hemicord 
 mouse sod1 p84 p   =   0.0001 n   =   25 hemisection n   =   6 hemi- 
 cord mouse sod1 p112 p   <   0.0001 n   =   27 hemisection 
 N   =   6 hemicord mouse Fig.   7e result 
 v1 inhibitory interneuron die late disease stage show 
 significant loss tdtomato-­ 
 positive neuron p112 en1 
 transcript lose early stage disease 
 Fig. 5 putative v1 ia interneuron Renshaw cell dysregulation sod1g93a mouse b colocalization en1 blue foxp2 orange Pvalb 
 purple transcript detect rnascope hiplexup   situ hybridization wt sod1g93a mouse b p112 c significant reduction inhibitory en1+/foxp2+/ 
 Pvalb+ neuron ventrolateral region spinal cord v1 Ia interneuron located sod1g93a mouse gray versus wt red p63 p112 nest 
 unpaired two-­ 
 tailed t test p63 p   =   0.0498 p112 p   =   0.0016 d spatial distribution count-­ 
 base kernel density estimation putative ia interneuron pool 
 p112 spinal cord section datum decrease En1+/ Foxp2+/Pvalb+ neuron sod1g93a mouse right/red compare healthy control left/gray e 
 F colocalization en1 blue calb1 orange transcript wt e sod1g93a spinal cord f p112 g marked loss inhibitory en1+/calb1 + neuron located 
 ventral spinal cord rcs find sod1g93a mouse p63 exacerbation p112 nest unpaire two-­ 
 tailed t test p63 p   =   0.0271 p112 
 p   =   0.0046 h spatial distribution putative rcs en1+/calb1 + p112 cell ventral spinal cord sod1g93a mouse compare healthy control mouse 
 evidence marked reduction en1+/calb1 + neuron scale bar 100 μm nt counterstaining gray 2d kernel density d h plot 10 bin 
 viridis scale n   =   6 hemicord mouse fill number hemisection p30 n(wt   =   22 n(sod1   =   20 p63 n(wt   =   22 n(sod1   =   21 p112 n(wt   =   23 
 n(sod1   =   26 datum show mean   ±   sd 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 9 18 
 Fig. 6 inhibitory neurotransmitter marker late affection sod1g93a mouse b e F J Microscopy image show detection transcript blue 
 rnascope hiplexup   situ hybridization healthy control mouse sod1g93a mouse p112 glyt2 b gad67 e f gad65 j nt 
 counterstaining gray c g k quantification positive cell different neurotransmitter marker sod1g93a mouse red versus healthy control gray datum 
 significant decrease glyt2 + neuron p112 c nest unpaire two-­ 
 tailed t test p30 p   =   0.7469 p63 p   =   0.3836 p112 p   =   0.0121 gad67 + cell 
 p112 g nest unpaire two-­ 
 tailed t test p30 p   =   0.9172 p63 p   =   0.1398 p112 p   =   0.0014 change gad65 + cell k nest unpaire two-­ 
 tailed t test p30 
 p   =   0.6879 p63 p   =   0.2101 p112 p   =   0.3431 d h l spatial distribution show location count-­ 
 base kernel density estimation glyt2 + d gad67 + 
 h gad65 + l cell spinal cord healthy control left/red sod1g93a right/gray mouse p112 scale bar 100 μm 2d kernel density d h 
 l plot 10 bin viridis scale n   =   6 hemicord mouse fill number hemisection p30 n(wt   =   22 n(sod1   =   20 p63 n(wt   =   22 
 n(sod1   =   21 p112 n(wt   =   23 n(sod1   =   26 datum show mean   ±   sd 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 10 18 
 Glutamatergic v2a neuron lose chx10 transcript late 
 disease shox2+/chx10− v0 g interneuron remain 
 unaffected vglut2 expression 
 excitatory glutamatergic vglut2 + interneuron analyze 
 different time point investigate population 
 v2a chx10 + shox2 + divide chx10 + 
 chx10− v0 g pitx2 + v2a interneuron define 
 chx10 + neuron find intermediate area spinal cord 
 compare transcript expression wt sod1g93a 
 mouse Fig.   8 b steep down-­ 
 regulation 57.6 ob- 
 serve p112 p30 nest unpaire two-­ 
 tailed t test t   =   1.392 
 df   =   10 p   =   0.1941 n   =   22 20 hemisection n   =   6 hemicord 
 mouse condition p63 nest unpaire two-­ 
 tailed t 
 test t   =   0.110 df   =   10 p   =   0.9150 n   =   22 21 hemisection n   =   6 
 hemicord mouse condition p112 nest unpaire 
 two-­ 
 tailed t test t   =   4.894 df   =   47 p   <   0.0001 n   =   23 26 hemisec- 
 tion n   =   6 hemicord mouse condition Fig.   8c 
 analysis spatial distribution p112 reveal change 
 ventral dorsal area Fig.   8d change ob- 
 serve p30 p63 fig.   s7 b 
 shox2 + neuron divide shox2+/chx10 + shox2+/ 
 chx10− 17 Fig.   8 e h subpopulation differen- 
 tially affect sod1g93a mouse case shox2+/chx10 + 
 neuron significant 59.6 reduction p112 p112 
 nest unpaire two-­ 
 tailed t test t   =   4.410 df   =   10 p   =   0.0013 
 n   =   23 26 hemisection n   =   6 hemicord mouse 
 condition Fig.   8 g contrast change expres- 
 sion shox2+/chx10− neuron time point p112 nest- 
 ed unpaired two-­ 
 tailed t test t   =   0.137 df   =   47 p   =   0.8914 n   =   23 
 26 hemisection n   =   6 hemicord mouse condition 
 Fig.   8h change spatial distribution show Fig.   8i 
 shox2+/chx10 + neuron fig.   s7 c d overall shox2 + 
 shox2+/chx10− neuron 
 glutamatergic pitx2-­ 
 positive v0 g neuron located close 
 central canal 7 population remain unchanged 
 number pitx2-­ 
 positive neuron constant time point 
 Fig. 7 v1 interneuron fate sod1g93a mouse microscopy image p112 sod1g93a;en1cre;r26rtdtomato mouse lumbar spinal cord rnascope   situ hy- 
 bridization show tdtomato orange en1 blue chat violet transcript b c magnification tdtomato en1 chat transcript dapi counterstaining 
 gray intermediate area spinal cord p63 en1cre;r26rtdtomato healthy control mouse wt b p112 sod1g93a;en1cre;r26rtdtomato sod1 c d quantifica- 
 tion tdtomato+ cell healthy control en1cre;r26rtdtomato gray sod1g93a;en1cre;r26rtdtomato different time point red significant reduction tdtomato+ 
 cell observe sod1g93a group p112 nest one-­ 
 way anova Dunnett post hoc wt control group sod1 p63 p   =   0.4608 sod1 p84 p   =   0.6398 sod1 
 p112 p   =   0.0115 e percentage tdtomato+ cell positive en1 transcript healthy control versus sod1g93a group expression en1 transcript 
 reduce neuron sod1g93a mouse time point compare wt control nest one-­ 
 way anova Dunnett post hoc wt control group sod1 p63 
 p   <   0.0001 sod1 p83 p   =   0.0001 sod1 p112 p   <   0.0001 scale bar 200 μm 100 μm b c biological replicate hemicord show black techni- 
 cal replicate hemisection show gray sample size wt n   =   14 hemicord 7 mouse n   =   65 hemisection sod1 p63 n   =   6 hemicord mouse n   =   26 
 hemisection sod1 p84 n   =   6 hemicord mouse n   =   25 hemisection sod1 p112 n   =   6 hemicord mouse n   =   27 hemisection datum show 
 mean   ±   sd 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 11 18 
 sod1g93a mouse p30 nest unpaire two-­ 
 tailed t test t   =   1.765 
 df   =   40 p   =   0.0852 n   =   22 20 hemisection n   =   6 hemicord 
 mouse condition p63 nest unpaire two-­ 
 tailed t test 
 t   =   0.578 df   =   10 p   =   0.5762 n   =   22 21 hemisection n   =   6 hemi- 
 cord mouse condition p112 nest unpaire two-­ 
 tailed 
 t test t   =   0.294 df   =   10 p   =   0.7746 n   =   23 26 hemisection n   =   6 
 hemicord mouse condition figs.   s8 d s9 
 b d f h 
 chx10 + shox2 + v0 g pitx2 + neuron positive 
 vesicular glutamate transporter 2 vglut2 7 17 
 investigate vglut2 expression time point Fig.   9 
 change detect vglut2 expression stage p30 nest ­NHCDVCD­C­DCCNHEDCDCCH­CCCDCNTDDNDDDDD 
 Fig. 8 v2a shox2 + 
 v2a interneuron dysregulate late stage disease sod1g93a mouse b rnascope hiplexup   situ hybridization 
 microscopy image show detection chx10 transcript green lumbar spinal cord healthy control wt sod1g93a mouse b p112 c significant reduc- 
 tion number excitatory vglut2 + chx10 + neuron sod1g93a mouse red compare healthy control mouse gray p112 nest unpaire two- 
 tailed t 
 test p30 p   =   0.1941 p63 p   =   0.9150 p112 p   <   0.0001 d spatial distribution excitatory chx10 + neuron count- 
 base kernel density estimation sod1g93a mouse 
 right/gray versus healthy control mouse left/red pool p112 section loss positive cell intermediate region spinal cord e F colocal- 
 ization chx10 green shox2 violet transcript RnAscope hiplexup wt e sod1g93a spinal cord f p112 g h quantification excitatory shox2 + 
 neuron combination chx10 + sod1g93a mouse versus healthy control mouse p112 reveal steep decrease shox2+/chx10 + neuron g change 
 shox2+/chx10− h nest unpaire two- tail t test shox2 + p   =   0.0137 shox2+/chx10− p   =   0.8914 shox2+/chx10 + p   =   0013 spatial distribution shox2+/ 
 chx10 + neuron spinal cord p112 sod1g93a mouse versus healthy control mouse show similar pattern observe chx10 + neuron scale bar 
 100 μm nt counterstaine gray 2d kernel density d plot 10 bin viridis scale n   =   6 hemicord mouse fill number 
 hemisection p30 n(wt   =   22 n(sod1   =   20 p63 n(wt   =   22 n(sod1   =   21 p112 n(wt   =   23 n(sod1   =   26 datum show mean   ±   sd 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 12 18 
 unpaired two-­ 
 tailed t test t   =   1.557 df   =   40 p   =   0.1273 n   =   22 
 20 hemisection n   =   6 hemicord mouse condition 
 p63 nest unpaire two-­ 
 tailed t test t   =   1.832 df   =   30 p   =   0.0742 
 n   =   22 21 hemisection n   =   6 hemicord mouse 
 condition p112 nest unpaire two-­ 
 tailed t test t   =   0.099 df   =   10 
 p   =   0.9225 n   =   23 26 hemisection n   =   6 hemicord 
 mouse condition Fig.   9c difference spatial 
 distribution Fig.   9d fig.   s10 
 datum suggest excitatory population 
 affect late disease case specific marker 
 lose neurotransmitter chx10 
 shox2 population differential vulnerability regard 
 transcription factor chx10 + shox2+/chx10 + neuron be- 
 ing affect p112 shox2+/chx10− pitx2 + neuron 
 appear resistant 
 cholinergic population affect p112 
 v0c interneuron 
 chat marker know down-­ 
 regulate muscle de- 
 nervation 45 somatic motor neuron loss observe p112 
 sod1g93a mouse model 27 46 47 find 
 down-­ 
 regulation chat+ cell located ventral 
 spinal cord correspond putative somatic motor neuron 
 p112 p112 nest unpaire two-­ 
 tailed t test t   =   2.348 df   =   47 
 p   =   0.0231 n   =   23 26 hemisection n   =   6 hemicord 
 mouse condition 28.4 loss fig.   s11 v0c interneu- 
 ron positive pitx2 chat 7 analyze figs.   s8 
 s9 c e g population know rise 
 c bouton 7 8) affect investigate time 
 point p30 nest unpaire two-­ 
 tailed t test t   =   0.257 df   =   40 
 p   =   0.7989 n   =   22 20 hemisection n   =   6 hemicord 
 mouse condition p63 nest unpaire two-­ 
 tailed t test t   =   0.578 
 df   =   10 p   =   0.6215 n   =   22 21 hemisection n   =   6 hemicord 
 mouse condition p112 nest unpaire two-­ 
 tailed t 
 test t   =   0.123 df   =   10 p   =   0.6579 n   =   23 26 hemisection n   =   6 
 hemicord mouse condition fig.   s9 c e g 
 expect motor neuron affect sod1g93a mouse 
 symptomatic stage cholinergic interneu- 
 ron population remain unaffected term transcript expression 
 DISCUSSION 
 study show spinal interneuron exhibit differential sus- 
 ceptibility disease progression mouse model als inhibitory 
 interneuron exhibit early onset start p63 characterize 
 slow loss neuronal identity follow cell death late stage 
 excitatory interneuron display later onset start p112 
 fast loss transcript 
 condition success study development 
 method reliably detect coexpression multiple marker 
 spinal cell population develop analysis pipeline en- 
 able tracing cell population high fidelity base 
 detection quantification multiple marker ap- 
 proach obtain quantitative dataset relative change 
 transcript expression subpopulation spinal interneuron 
 disease progression sod1g93a mouse line 
 demonstrate molecular marker hitherto consid- 
 ere express development present adulthood 
 Fig. 9 expression vglut2 excitatory transcript show change sod1g93a mouse b microscopy image rnascope hiplexup   situ hybridiza- 
 tion show vglut2 transcript green lumbar spinal cord wt sod1g93a mouse b p112 nt gray c quantification vglut2 + neuron sod1g93a 
 mouse versus healthy control mouse reveal change test time point nest unpaire two-­ 
 tailed t test p30 p   =   0.1273 p63 p   =   0.0742 p112 p   =   0.9225 
 d spatial distribution vglut2 + neuron spinal cord healthy control mouse right/gray sod1g93a mouse left/red p112 include count-­ 
 base kernel 
 density estimation apparent high density observe sod1g93a mouse effect high number section group scale bar 100 μm 2d 
 kernel density d plot 10 bin viridis scale n   =   6 hemicord mouse fill number hemisection p30 n(wt   =   22 n(sod1   =   20 
 p63 n(wt   =   22 n(sod1   =   21 p112 n(wt   =   23 n(sod1   =   26 datum show mean   ±   sd 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 13 18 
 spinal cord tissue marker delineate 
 specific cell population derive developmental progenitor 
 finding allow use transcript cellular marker 
 adult mouse spinal cord 
 particular interest v1 interneuron give early 
 dysregulation involvement sod1g93a locomotor pheno- 
 type 27 study reveal distinct pattern dysregulation 
 transcription factor expression different v1 interneuron 
 population find putative rcs high susceptibil- 
 ity disease follow putative ia interneuron foxp2-­ 
  
 Pou6f2-­ 
 positive neuron lastly sp8-­ 
 positive neuron 
 analysis renshaw cell rc ia interneuron degeneration 
 rely putative definition population interest 
 assert neuronal population involve marker 
 widely accept field identify rcs 
 Ia interneuron 12 48 49 
 study reveal putative rcs lose marker en1 
 calb1 early disease course corroborate early research in- 
 dicate loss calb1-­ 
 positive neuron sod1g93a mouse 
 model loss previously document 10 week p70 
 immunohistochemistry 50 subsequent loss calb1 mrna 
 protein observe p80 p100 respectively 51 addition 
 calbindin-­ 
  gephyrin-­ 
 positive neuron report diminish 
 model 52 finding contrast 
 Salamatina et al. 29 investigate v1 interneuron 
 sod1g93a mouse observe change antibody labeling 
 putative rcs discrepancy result 
 Salamatina et al. 29 stem methodological experi- 
 mental design difference notably Salamatina et al. 29 report 
 low average number rcs 0.5 1.5 cell hemicord 
 control mouse compare cell hemicord find 
 study low detection level research 
 affect ability observe change protein level contrib- 
 uting differ outcome lack observe change 
 pou6f2 Salamatina et al. 29 explain dif- 
 ference previously note study like Wootz et al. 51 altera- 
 tion mrna level precede protein level change 
 explain observe difference study nonetheless 
 study identify similar pattern loss foxp2 sp8 neu- 
 ron case chx10-­ 
 positive neuron finding 
 show similar pattern loss report Salamatina et al. 
 29 albeit pronounced begin p110 onset 
 slightly later loss report romer et al. 28 
 point divergence study previous research 
 spatial mapping v1 neuron observe segregate 
 map pou6f2 sp8 foxp2 previously report anti- 
 body staining study 13 14 29 discrepancy arise 
 difference method sensitivity presentation spatial 
 map bikoff et al. 13 contour plot represent 30th 90th per- 
 centile 60th 90th percentile density restricted range 
 density cutoff apply 
 contour plot include positive neuron find 
 multiple technical replicate overlap 13 
 29 similar contour cutoff presumably 
 regard cell fate result v1 inhibitory 
 interneuron lose en1 transcript early stage disease 
 die later stage transcription factor es- 
 sential cell differentiation play crucial role 
 maintain neuronal fate adult postmitotic neuron 53 
 research demonstrate deplete specific neuron-­ 
 type 
 gene adulthood lead disturbance neural identity 
 neurotransmitter level neuron type include dopami- 
 nergic serotonergic cholinergic neuron 54–56 disruption 
 postmitotic maintenance mechanism initiate neuro- 
 degenerative condition 53 context study similar 
 mechanism play early loss en1 disease pro- 
 cess contribute factor initiate v1 neuron degen- 
 eration eventually follow down-­ 
 regulation 
 neurotransmitter marker glyt2 late stage dis- 
 ease cell death take account previous finding 
 event occur inhibitory v1 interneuron lose 
 connectivity motor neuron 27 
 observe change excitatory marker 
 coincide motor neuron death finding clearly demon- 
 strate inhibitory interneuron dysregulation precede motor 
 neuron death change balance inhibitory/ex- 
 citatory synaptic input motor neuron pronounced 
 motor neuron degeneration reflect large consecutive impair- 
 ment spinal inhibitory excitatory circuit disease inhibi- 
 tory neurotransmitter deficit emerge late stage disease 
 compare transcription factor imply presence 
 reservoir transmitter early disease suggest main- 
 tenance inhibitory/excitatory phenotype neuron de- 
 spite ongoing degeneration down-­ 
 regulation transcription 
 factor especially inhibitory population aspect 
 target potential als treatment aim maintain circuit 
 connectivity 35 restore excitatory/inhibitory balance 
 motor neuron 
 observe degeneration specific spinal interneuron sub- 
 population raise key question mechanism underlie 
 selective vulnerability definitive answer remain 
 elusive possible framework suggest Salamatina et al. 
 29 propose interneuron direct motor neuron connec- 
 tivity prone degeneration explanation align 
 available datum vulnerability rcs ia inter- 
 neuron shox2 + v2a neuron locomotor pheno- 
 type previously describe sod1g93a mouse 27 
 explain unique loss last-­ 
 order v1 interneuron projec- 
 tion loss speed change cadence suggest change 
 rhythm modulation process occur motor neu- 
 ron level consequently plausible loss extend 
 v1 neuron project motor neuron encompass v1 
 interneuron interneuron projec- 
 tion v0c interneuron project motor 
 neuron c bouton appear affect sod1g93a 
 mouse investigate time point 7 
 gene discovery study investigate molecular 
 change interneuron motor neuron time require 
 clarify interneuron initial target degeneration 
 subsequently spread disease anterogradely motor neuron 
 degenerate retrograde signal motor neuron 
 connectivity loss strong indication role inhibi- 
 tory interneuron disease initiation loss v1 synaptic input 
 motor neuron precede transcript down-­ 
 regulation 
 neuronal death 27 type morphological evidence point to- 
 ward anterograde cascade start inhibitory interneuron 
 idea support recent study report motor deficit 
 motor neuron loss en1 down-­ 
 regulation 57 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 14 18 
 gain insight potential role synaptic spread 
 disease crucial conduct comprehensive analysis 
 connectivity pattern different interneuron population 
 fast/slow motor neuron healthy diseased condition 
 addition investigate molecular mechanism underlie 
 describe synaptic loss provide valuable information en- 
 deavor potential shed light intricate mechanism 
 drive selective vulnerability observe spinal interneuron 
 material method 
 experimental animal 
 animal experiment perform accordance EU 
 Directive 20110/63/eu approve Danish Animal Inspec- 
 torate Dyreforsøgstilsynet ethical permit 2018-­ 
 15-­ 
 0201-­ 
 01426 
 Department Experimental Medicine Faculty Health 
 Medical Sciences wt c57bl6/j mouse Jackson Laboratory strain 
 000664   situ sequencing experiment heterozy- 
 gous sod1g93a mouse Jackson Laboratory strain 004435 -­ 
  b6.cg-­ 
 tg(sod1*g93a)1gur/j als model v1 
 interneuron fate experiment sod1g93a mouse cross 
 heterozygous en1cre mouse gift J. Bikoff St. Jude Children 
 Hospital St Louis tx usa homozygous R26RtdTomato Jackson 
 Laboratory strain 007914 -­ 
  b6.cg-gt(rosa)26sortm14(cag- 
 tdtomato)hze/j strain multiple transgenic keep 
 c57bl6/j genetic background experiment sod1g93a 
 mouse wt littermate control genotyping sod1g93a 
 perform follow supplier instruction quantification 
 human mutate sod1 copy number quantitative polymerase 
 chain reaction Jackson sod1g93a founder breeder carry 25 
 copy human mutate sod1 gene positive con- 
 trol SOD1127X carry 19 copy negative con- 
 trol mouse group-­ 
 house 12:12-­ 
 hour light dark cycle 
 food water ad    libitum 23 ° 24 ° c temperature 45 
 65 humidity 
 preparation fresh-­ 
 frozen tissue 
 sample collect p1 p28   situ sequencing experi- 
 ment p30 p63 p112 rnascope hiplexup experiment 
 p63 p84 p112 v1 fate experiment male 
 female mouse anesthetize overdose pen- 
 tobarbital solution 250 mg/kg euthanize decapitation 
 lumbar region spinal cord quickly dissect free 
 remove vertebrate canal fresh-­ 
 frozen immersion 
 dry ice-­ 
 cold isopentane cryoprotection well preserva- 
 tion sample store −80 ° c section closely 
 use spinal cord coronal section embed tissue-­ 
 Tek 
 OCT Compound Sakura ref 4583 cut cryostat 12 μm 
 Thermo Fisher Scientific cryostar nx70 Microm hm550 col- 
 lecte SuperFrost plus glass slide Thermo Fisher Scientific 
 store −80 ° c avoid rna degradation equip- 
 ment tool involve rna work clean rnasezap 
 Thermo Fisher Scientific am9780 am9786 use 
 situ sequence 
 assay 
 situ sequencing perform cartana Library Prep 
 Kit CARTANA/10x Genomics art no. 1010-­ 
 01/02 later replace 
 Xenium 10x Genomics sample preparation perform 
 describe user manual doc no. d023 briefly sample 
 fixate provide fixation solution follow incubation 
 permeabilization solution dehydration ethanol series 
 rehydration sample incubate reverse transcription 
 postfixation padlock probe ligation roll circle amplification 
 fluorescent labeling provide mix dehydrate 
 mount follow supplier instruction incubation 
 perform SecureSeal Hybridization Chambers Grace Bio-­ 
 Labs ref 621502 chimeric padlock probe custom 
 cartana include 24 neuron marker Fig.   1b 
 pitx2 evx1 chat en1 foxp2 pou6f2 sp8 lmo3 bhlhb5 nr3b3 
 nr4a2 prdm8 calb1 calb2 Pvalb chx10 shox2 mnx1 vglut2 
 glyt2 gad67 gad65 lhx1 lhx5 quality control per- 
 form anchor probe label cy3 fluorophore detect 
 amplification product quality control image take in-­ 
 house 20 × air objective Zeiss Axio Imager z1 
 Zeiss Axio Scan z1 slide scanner ec plan-­ 
 Neofluar 20 × /0.50 m27 
 plan-­ 
 Apochromat 20 × /0.8 m27 respectively 0.227 μm/pixel 
 approve CARTANA/10x Genomics process sample 
 send CARTANA/10x Genomics   situ barcode se- 
 quencing imaging datum processing briefly adapter probe 
 sequencing pool contain af488 cy3 cy5 af750 label 
 hybridize ligate padlock probe detect nu- 
 cleotide gene-­ 
 specific barcode sequence-­ 
 specific 
 signal follow imaging perform time 
 row allow decoding barcode probe raw datum 
 obtain Nikon microscope system 40 × objective 
 0.165 μm/pixel cfi plan-­ 
 Apochromat λ 20 × /0.75 0.32 μm/ 
 pixel image include dapi plus sequencing label 
 take z-­ 
 stack flatten maximum intensity projection 
 sequencing sample send staining 
 NeuroTrace 530/615 640/660 invitrogen n21482 n21483 
 segmentation purpose perform 2-­ 
 hour incuba- 
 tion room temperature 1:200 phosphate-­ 
 buffered saline pbs 
 Image datum processing 
 image sequencing processing cartana/10x genom- 
 ic datum receive include dapi image sequence spinal 
 cord section csv file gene identity coordinate 
 pixel unit 0.32 μm/pixel detect transcript transcript datum 
 present format low high threshold 
 low threshold neurotrace imaging perform us- 
 ing Zeiss Axio Imager z1 Zeiss Axio Scan z1 slide scanner 
 EC plan-­ 
 Neofluar 20 × /0.50 m27 plan-­ 
 Apochromat 20 × /0.8 m27 
 respectively 0.227 μm/pixel dapi counterstaining reim- 
 aged neurotrace later image registration cell 
 segmentation base neurotrace staining perform 
 custom-­ 
 deep learning model Fig.    2a segmentation 
 model base ensemble cnn train cross-­ 
 validate 
 different partition partial manually annotate image datum 
 specifically u-­ 
 net type architecture CNN configura- 
 tion ensemble member prediction ensemble net- 
 work yield probabilistic segmentation map presence 
 neuron cell boundary delineation obtain 0.4 
 confidence threshold structural kernel 5 probabilis- 
 tic segmentation mask cell segmentation result regis- 
 tere sequencing datum base NeuroTrace dapi 
 DAPI obtain   situ sequencing assay keypoint-­ 
 base 
 registration random sample consensus ransac 58 algo- 
 rithm perform obtain transformation transformation 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 15 18 
 obtain register dapi apply neurotrace 
 cell segmentation register cell colocalize 
 transcript cartana transcript localize with- 
 segment cell consider total n   =   6 spinal cord sec- 
 tion mouse p1 n   =   29 section 11 mouse 
 p28 process analyze analysis perform 
 rstudio spatial profiling quantification section code 
 https://doi.org/10.5281/zenodo.10600983 
 quantitative multiplexe   situ hybridization 
 rnascope hiplexup 
 assay 
 Quantitative multiplexe   situ hybridization perform 
 rnascope hiplex12 reagent 488 550 647 kit assay ad- 
 vance cell diagnostics/bio-­ 
 Techne catalog no. 324194 re- 
 place HiPlex v2 assay combination rnascope 
 HiPlexUp Reagent advanced Cell diagnostics/bio-­ 
 Techne catalog 
 no. 324190 sample pretreatment hiplexup assay per- 
 form describe user manual 324100-­ 
 UM briefly sam- 
 ple pretreate fixation 4 paraformaldehyde 
 extend 90 min compare supplier ethanol dehydra- 
 tion incubation provide protease hiplex12 
 assay perform hybridization 12 
 probe follow overnight storage 5 × ssc room tempera- 
 ture amplification sequential probe labeling imaging 
 fluorophore cleave fig.   s2a notably concentration 
 Tween pbst reduce 0.05 assay adapt 
 use fluorescent channel round fluorophore 
 instead 12 probe image 
 cleave hiplexup reagent second round 
 hiplex12 process manner fig.   s2a combi- 
 nation probe fluorophore include catalog number 
 list table   1 assay sample stain neu- 
 rotrace 530/615 invitrogen n21482 2-­ 
 hour incubation 
 room temperature 1:200 pbs reimage segmentation 
 purpose counterstaine dapi provide kit per- 
 form describe manual 30-­ 
 s incubation 
 mounting imaging round image 
 round include NeuroTrace image registration 
 image acquisition processing 
 imaging round perform Zeiss Axio Scan z1 
 slide scanner sod1 sample corresponding age-­ 
 matching 
 control process image microscopy 
 setting sample imaging round coronal 
 spinal cord section scan plan-­ 
 Apochromat 20 × /0.8 
 m27 air objective 0.227 μm/pixel z-­ 
 stack slice in- 
 crement 2.5 μm autofocuse base dapi staining 
 minimum section space 120 μm apart image 
 mouse mouse condition time point 
 ZEN software Zeiss ZEN desk version 3.5 result tile 
 Table 1 rnascope hiplexup probe probe specific mouse 
 hiplexup round 
 hiplex12 round 
 Marker 
 Catalog no. 
 Fluorophore 
 1 
 1 
 lhx5 
 885621-­ 
 t1 
 af488 
 bhlhb5 
 467641-­ 
 t2 
 atto550 
 pitx2 
 412841-­ 
 t3 
 atto647n 
 2 
 nr4a2 
 423351-­ 
 t4 
 af488 
 shox2 
 579051-­ 
 t5 
 atto550 
 pou6f2 
 839401-­ 
 t6 
 atto647n 
 3 
 foxp2 
 428791-­ 
 t7 
 af488 
 nr3b3 errg 
 495121-­ 
 t8 
 atto550 
 slc17a6 vglut2 
 319171-­ 
 t9 
 atto647n 
 4 
 calb1 
 428431-­ 
 t10 
 af488 
 chat 
 1029981-­ 
 t11 
 atto550 
 gad1 gad67 
 400951-­ 
 t12 
 atto647n 
 2 
 5 
 lhx1 
 488581-­ 
 t1 
 af488 
 lmo3 
 497631-­ 
 t2 
 atto550 
 evx1 
 509161-­ 
 t3 
 atto647n 
 6 
 en1 
 442651-­ 
 t4 
 af488 
 vsx2 chx10 
 438341-­ 
 t5 
 atto550 
 prdm8 
 467501-­ 
 t6 
 atto647n 
 7 
 mnx1 hb9 
 1063561-­ 
 t7 
 af488 
 sp8 
 547521-­ 
 t8 
 atto550 
 slc6a5 glyt2 
 409741-­ 
 t9 
 atto647n 
 8 
 Pvalb 
 421931-­ 
 t10 
 af488 
 calb2 calretinin 
 485811-­ 
 t11 
 atto550 
 gad2 gad65 
 439371-­ 
 t12 
 ATTO647N 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 16 18 
 image split scene scene correspond differ- 
 ent section image round—728 hiplexup image plus 91 neu- 
 rotrace image ii stitch base dapi staining iii z-­ 
 stack 
 flatten maximum intensity projection iv single-­ 
 channel image marker export tif format keep- 
 ing original quality 3094 image fig.   s2a section 
 break fold discard point sec- 
 tion mouse keep image different round origi- 
 nating section register basis 
 dapi staining Register Virtual Stack Slices trans- 
 form Virtual Stack Slices plugin Fiji imagej 2.3.0/1.53f51 
 merge single image 68 image 26 channel neu- 
 rotrace dapi 24 interneuron marker fig.    s2a 
 merged image convert czi format anal- 
 ysis improve segmentation reduce file size image 
 crop include gray matter region spinal cord 
 ZEN software Extract polygon macro fig.   s2a 
 segment basis neurotrace staining 
 ZEN software intellesis tool 80 confidence split cell water- 
 shed 50-­ 
 μm minimum size analyze obtain coordinate 
 marker intensity profile include intensity mean sd 
 detect cell fig.   s2b detect positive cell intensity thresh- 
 old select image interneuron marker base 
 signal background intensity mean transcript 
 abundant widespread signal intensity sd 
 transcript sparse signal group hemicord 
 mouse include hemisection 
 analyze hemicord table   s1 analysis perform 
 rstudio spatial profiling quantification section 
 code https://doi.org/10.5281/zenodo.10600965 
 spatial profiling quantification 
 coordinate normalization spatial profiling positive cell 
 quantification   situ sequencing quantitative rnascope 
 hiplexup   situ hybridization perform custom anal- 
 ysis pipeline script rstudio 2022.02.1 build 461 code 
 https://doi.org/10.5281/zenodo.10600983 https://doi.org/10.5281/­ 
 zenodo.10600965 orientation angle individual image 
 central canal coordinate maximum width height 
 hemisection measure coordinate normalization stan- 
 dardized mouse spinal cord hemisection spinal cord orientation 
 correct rearrr::rotate_2d function leave right hemi- 
 section split basis coordinate central 
 canal dplyr::mutate function coordinate cor- 
 recte hemisection size position basic r function 
   situ sequencing normalization standardized dimension 
 spinal cord follow 2050 pixel 656 μm mediolat- 
 eral 2950 pixel 944 μm dorsoventral early postnatal p1 3450 
 pixel 1104 μm mediolateral 4400 pixel 1408 μm dorsoventral 
 young adult p28 Fig.   2a rnascope hiplexup adult stan- 
 dardized dimension gray matter 930 μm mediolat- 
 eral 1280 μm dorsoventral fig.    s2b x axis define 
 parallel mediolateral axis medial origin y axis 
 define parallel dorsoventral axis ventral origin 
   situ sequencing experiment transcript localize 
 segment cell visualize consider qualitative 
 analysis colocalization en1 transcript v1 marker 
 visualize represent v1 subpopulation rnascope hi- 
 plexup experiment positive cell marker identify 
 basis select intensity threshold describe 
 basic r function combination marker cell coordinate 
 describe quantify putative interneuron population 
 spatial distribution estimate count calculate 
 two-­ 
 dimensional kernel density estimation ggplot2::geom 
 density_2d_filled function count_var   =   count argument 
 display 10 bin viridis scale density cutoff 
 situ hybridization rnascope 
 assay 
 assessment v1 interneuron fate   situ hybridization per- 
 form rnascope Multiplex Fluorescent V2 assay ad- 
 vance cell diagnostics/bio-­ 
 Techne catalog no. 323100 sample 
 pretreatment assay perform describe fresh frozen 
 sample user manual 323100-­ 
 USM 27 over- 
 night storage sample 5 × ssc room temperature probe 
 hybridization follow probe advanced cell diagnostics/ 
 bio-­ 
 Techne mm-­ 
 en1-­ 
 c1 catalog no. 442651 tdtoma- 
 to-­ 
 c3 catalog no. 317041-­ 
 c3 mm-­ 
 chat-­ 
 c2 counterstaine 
 catalog no. 408731-­ 
 c2 opal 690 570 520 dye Akoya Biosci- 
 ence fp1497001kt fp1488001kt fp147001kt 
 fluorophore respectively 1:1500 trichostatin buffer tsa pro- 
 vide kit dapi counterstaining provide 
 kit 
 image acquisition processing analysis 
 Images acquire Zeiss Axio Scan z1 slide scanner 
 Plan-­ 
 Apochromat 20 × /0.8 m27 air objective 0.227 μm/pixel 
 z-­ 
 stack slice increment 1.5 μm autofocuse base 
 dapi staining minimum section 120 μm apart 
 image mouse mouse condition time point 
 ZEN software Zeiss ZEN desk version 3.5 image 
 split scene stitch base dapi staining z-­ 
 stack flat- 
 tene maximum intensity projection ventral region 
 hemisection crop 760 μm × 650 μm 
 segment basis tdtomato transcript signal ZEN 
 software intellesis tool 80 confidence split cell watershe 
 50-­ 
 μm minimum size analyze obtain cell coordinate 
 intensity profile number segment cell 
 quantify tdtomato+ cell tdtomato+/en1 + quantification 
 obtain basis en1 intensity sd threshold 
 segment cell normalize tdtomato+ number calculate 
 percentage 
 statistical analysis 
 statistical analysis perform GraphPad Prism 
 software version 10.1.2(324 sample size predetermine 
 statistical method instead similar previous pub- 
 lication Allodi et al. 27 experiment mouse 
 randomly allocate different group block design datum 
 collection blind experimental group allocation 
 semiautomate analysis datum perform blind mouse 
 include dataset rnascope hiplexup datum 
 analyze nest unpaire two-­ 
 tailed t test effect size 
 calculate Cohen ds base statistical datum follow 
 formula ds = t 
 √ 
 nwt + nsod1)∕(nwtnsod1 t t test value 
 n number section classify trivial < 0.2 
 small 0.2 0.49 medium 0.5 0.79 large ≥0.8 suggest 
 Cohen 59 report mean calculate nest 
 datum figure datum present individual value replicate 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 17 18 
 shape mean value hemicord fill shape 
 mean   ±   sd hemicord value corresponding statistical val- 
 ue include n n t df p value specify text 
 figure legend extra information include mean differ- 
 ence   ±   sem 95 confidence interval difference effect size 
 find table   s1 s3 v1 interneuron fate datum ana- 
 lyze nest one-­ 
 way anova Dunnett post hoc 
 wt control group datum present individual 
 replicate gray mean value hemicord black 
 mean   ±   sd hemicord corresponding statistical value in- 
 cluding n n FDFn DFd p value specify text 
 figure legend statistical significance report follow 
 p   <   0.05 p   <   0.01 p   <   0.001 p   <   0.0001 
 Supplementary Materials 
 PDF file include 
 Figs.   s1 s11 
 table   s1 s3 
 references notes 
	  1 	  J. Nijssen L. H. Comley E. Hedlund Motor neuron vulnerability resistance 
 amyotrophic lateral sclerosis Acta Neuropathol 133 863–885 2017 
	  2 	  O. Kiehn Locomotor circuit mammalian spinal cord annu Rev. Neurosci 29 
 279–306 2006 
	  3 	  O. Kiehn decode organization spinal circuit control locomotion nat Rev. 
 Neurosci 17 224–238 2016 
	  4 	  J. Briscoe A. Pierani T. M. Jessell J. Ericson homeodomain protein code specify 
 progenitor cell identity neuronal fate ventral neural tube cell 101 435–445 
 2000 
	  5 	  S. Grillner A. El Manira intrinsic operation network locomote 
 Curr opin neurobiol 31 244–249 2015 
	  6 	  R. M. Brownstone T. V. Bui spinal interneuron provide input final common path 
 locomotion prog brain res 187 81–95 2010 
	  7 	  L. Zagoraiou T. Akay J. F. Martin R. M. Brownstone T. M. Jessell G. B. Miles cluster 
 cholinergic premotor interneuron modulate mouse locomotor activity neuron 64 
 645–662 2009 
	  8 	  G. B. Miles R. Hartley A. J. Todd R. M. Brownstone spinal cholinergic interneuron 
 regulate excitability motoneuron locomotion proc natl acad Sci u.s.a. 
 104 2448–2453 2007 
	  9 	  G. M. Lanuza S. Gosgnach A. Pierani T. M. Jessell M. Goulding genetic identification 
 spinal interneuron coordinate left-­ 
 right locomotor activity necessary walk 
 movement neuron 42 375–386 2004 
	 10 	  a. E. Talpalar J. Bouvier L. Borgius G. Fortin A. Pierani O. Kiehn dual-­ 
 mode operation 
 neuronal network involve left-­ 
 right alternation nature 500 85–88 2013 
	 11 	  C. Bellardita O. Kiehn phenotypic characterization speed-­ 
 associate gait change 
 mouse reveal modular organization locomotor network curr biol 25 1426–1436 
 2015 
	 12 	  F. J. Alvarez P. C. Jonas T. Sapir R. Hartley M. C. Berrocal E. J. Geiman A. J. Todd  
 M. Goulding postnatal phenotype localization spinal cord v1 derive 
 interneuron J. Comp neurol 493 177–192 2005 
	 13 	  J. B. Bikoff M. I. Gabitto A. F. Rivard E. Drobac T. A. Machado A. Miri s. brenner-­ 
 Morton 
 E. Famojure C. Diaz F. J. Alvarez G. Z. Mentis T. M. Jessell spinal inhibitory interneuron 
 diversity delineate variant motor microcircuit cell 165 207–219 2016 
	 14 	  M. I. Gabitto A. Pakman J. B. Bikoff L. F. Abbott T. M. Jessell L. Paninski Bayesian sparse 
 regression analysis document diversity spinal inhibitory interneuron cell 165 
 220–233 2016 
	 15 	  S. Gosgnach G. M. Lanuza S. J. Butt H. Saueressig Y. Zhang T. Velasquez D. Riethmacher 
 E. M. Callaway O. Kiehn M. Goulding v1 spinal neuron regulate speed vertebrate 
 locomotor output nature 440 215–219 2006 
	 16 	  s. a. Crone G. Zhong R. harris-­ 
 Warrick K. Sharma mouse lack v2a interneuron gait 
 depend speed locomotion J. Neurosci 29 7098–7109 2009 
	 17 	  K. J. Dougherty L. Zagoraiou D. Satoh I. Rozani S. Doobar S. Arber T. M. Jessell O. Kiehn 
 Locomotor rhythm generation link output spinal shox2 excitatory 
 interneuron neuron 80 920–933 2013 
	 18 	  L. Lundfald C. E. Restrepo S. J. Butt C. Y. Peng S. Droho T. Endo H. U. Zeilhofer  
 K. Sharma O. Kiehn phenotype v2-­ 
 derive interneuron relationship 
 axon guidance molecule epha4 develop mouse spinal cord eur J. Neurosci 26 
 2989–3002 2007 
	 19 	  J. Zhang G. M. Lanuza O. Britz Z. Wang V. C. Siembab Y. Zhang T. Velasquez F. J. Alvarez 
 E. Frank M. Goulding v1 v2b interneuron secure alternate flexor-­ 
 extensor 
 motor activity mouse require limbed locomotion neuron 82 138–150 2014 
	 20 	  O. Britz J. Zhang K. S. Grossmann J. Dyck J. C. Kim S. Dymecki S. Gosgnach  
 M. Goulding genetically define asymmetry underlie inhibitory control 
 flexor-­ 
 extensor locomotor movement elife 4 e04718 2015 
	 21 	  Y. Zhang S. Narayan E. Geiman G. M. Lanuza T. Velasquez B. Shanks T. Akay J. Dyck  
 K. Pearson S. Gosgnach C. M. Fan M. Goulding v3 spinal neuron establish robust 
 balanced locomotor rhythm walking neuron 60 84–96 2008 
	 22 	  J. W. Chopek F. Nascimento M. Beato R. M. Brownstone Y. Zhang sub-­ 
 population 
 spinal v3 interneuron form focal module layer pre-­ 
 motor microcircuit cell Rep. 
 25 146–156.e3 2018 
	 23 	  V. Caldeira K. J. Dougherty L. Borgius O. Kiehn Spinal hb9 cre-­ 
 derive excitatory 
 interneuron contribute rhythm generation mouse sci Rep. 7 41369 2017 
	 24 	  S. Mora I. Allodi Neural circuit synaptic dysfunction als-­ 
 ftd pathology 
 Neural circuit 17 1208876 2023 
	 25 	  L. R. Herron G. B. Miles gender-­ 
 specific perturbation modulatory input 
 motoneuron mouse model amyotrophic lateral sclerosis neuroscience 226 
 313–323 2012 
	 26 	  C. F. Cavarsan P. R. Steele L. T. Genry E. J. Reedich L. M. McCane K. J. LaPre A. C. Puritz 
 M. Manuel N. Katenka K. a. Quinlan inhibitory interneuron early dysfunction 
 sod1 mouse model amyotrophic lateral sclerosis J. Physiol 601 647–667 2023 
	 27 	  I. Allodi R. montanana-­ 
 Rosell R. Selvan P. Low O. Kiehn Locomotor deficit mouse 
 model als parallel loss v1-­ 
 interneuron connection fast motor 
 neuron nat commun 12 3251 2021 
	 28 	  S. H. Romer K. Seedle S. M. Turner J. Li M. L. Baccei S. a. Crone Accessory respiratory 
 muscle enhance ventilation als model mouse activate excitatory v2a 
 neuron exp neurol 287 192–204 2017 
	 29 	  a. Salamatina J. H. Yang S. brenner-­ 
 Morton J. B. Bikoff L. Fang C. R. Kintner T. M. Jessell 
 L. B. Sweeney differential loss spinal interneuron mouse model als 
 Neuroscience 450 81–95 2020 
	 30 	  F. Wang J. Flanagan N. Su L. C. Wang S. Bui A. Nielson X. Wu H. T. Vo X. J. Ma Y. Luo 
 rnascope novel   situ rna analysis platform formalin-­ 
 fix paraffin-­ 
 embedded 
 tissue J. Mol diagn 14 22–29 2012 
	 31 	  R. Ke M. Mignardi A. Pacureanu J. Svedlund J. Botling C. Wahlby M. Nilsson situ 
 sequencing rna analysis preserve tissue cell nat method 10 857–860 
 2013 
	 32 	  X. Qian K. D. Harris T. Hauling D. Nicoloutsopoulos A. B. munoz-­ 
 Manchado N. Skene  
 j. Hjerling-­ 
 Leffler M. Nilsson probabilistic cell typing enable fine mapping closely 
 related cell type   situ nat method 17 101–106 2020 
	 33 	  Y. Wang W. Wang D. Liu W. Hou T. Zhou Z. Ji genesegnet deep learning framework 
 cell segmentation integrate gene expression imaging genome Biol 24 235 
 2023 
	 34 	  X. Li Z. Andrusivova P. Czarnewski C. M. Langseth A. Andersson Y. Liu D. Gyllborg  
 E. Braun L. Larsson L. Hu Z. Alekseenko H. Lee C. Avenel H. K. Kallner E. Akesson  
 I. Adameyko M. Nilsson S. Linnarsson J. Lundeberg E. Sundstrom profile 
 spatiotemporal gene expression develop human spinal cord implication 
 ependymoma origin nat Neurosci 26 891–901 2023 
	 35 	  S. Mora R. von Huth Friis A. Stuckert G. Noes-­ 
 Holt R. montañana-­ 
 Rosell A. T. Sørensen 
 R. Selvan I. Allodi stabilization v1 interneuron-­ 
 motor neuron connectivity ameliorate 
 motor phenotype mouse model als biorxiv 2022.12.15.520568 2022 
	 36 	  P. Bankhead M. B. Loughrey J. A. Fernandez Y. Dombrowski D. G. McArt P. D. Dunne  
 S. McQuaid R. T. Gray L. J. Murray H. G. Coleman J. A. James m. salto-­ 
 Tellez  
 P. W. Hamilton QuPath open source software digital pathology image analysis sci 
 Rep. 7 16878 2017 
	 37 	  J. M. Kaminski I. Allodi R. montañana-­ 
 Rosell R. Selvan O. Kiehn deep ensemble model 
 segment microscopy image presence limited label datum paper 
 present MIDL 2021 Conference Lübeck Germany 7 9 July 2021 
	 38 	  M. Goulding circuit control vertebrate locomotion move new direction nat 
 Rev. Neurosci 10 507–518 2009 
	 39 	  O. Kiehn development functional organization spinal locomotor circuit curr 
 opin neurobiol 21 100–109 2011 
	  40 	  N. Lubben E. Ensink G. A. Coetzee V. Labrie enigma implication brain 
 hemispheric asymmetry neurodegenerative disease brain Commun 3 fcab211 2021 
	 41 	  J. Ravits P. Paul C. Jorg focality upper low motor neuron degeneration 
 clinical onset als neurology 68 1571–1575 2007 
	 42 	  Y. Mochizuki T. Mizutani T. Takasu Amyotrophic lateral sclerosis marked 
 neurological asymmetry clinicopathological study Acta Neuropathol 90 44–50 1995 
	 43 	  a. acevedo-­ 
 Arozena B. Kalmar S. Essa T. Ricketts P. Joyce R. Kent C. Rowe A. Parker  
 A. Gray M. Hafezparast J. R. Thorpe L. Greensmith E. M. Fisher comprehensive 
 Downloaded https://www.science.org June 01 2024 
 Montañana-Rosell et al. Sci adv 10 eadk3229 2024      31 2024 
 s c e n c e   d va n c e s   | r e s e r c h   r t c l e 
 18 18 
 assessment sod1g93a low-­ 
 copy transgenic mouse model human 
 amyotrophic lateral sclerosis dis model mech 4 686–700 2011 
	 44 	  L. Madisen T. A. Zwingman S. M. Sunkin S. W. oh H. A. Zariwala H. Gu L. L. Ng  
 R. D. Palmiter M. J. Hawrylycz A. R. Jones E. S. Lein H. Zeng robust high-­ 
 throughput cre reporting characterization system mouse brain nat 
 Neurosci 13 133–140 2010 
	 45 	  L. R. Fischer D. G. Culver P. Tennant a. a. Davis M. Wang a. castellano-­ 
 Sanchez J. Khan 
 M. a. Polak J. D. Glass Amyotrophic lateral sclerosis distal axonopathy evidence 
 mouse man exp neurol 185 232–240 2004 
	  46 	  a. M. Schaefer J. R. Sanes J. W. Lichtman compensatory subpopulation motor neuron 
 mouse model amyotrophic lateral sclerosis J. Comp neurol 490 209–219 2005 
	 47 	  I. Allodi L. Comley S. Nichterwitz M. Nizzardo C. Simone J. A. Benitez M. Cao S. Corti  
 E. Hedlund differential neuronal vulnerability identify igf-­ 
 2 protective factor 
 als sci Rep. 6 25960 2016 
	  48 	  F. J. Alvarez D. E. Dewey p 
 McMillin R. E. Fyffe Distribution cholinergic contact 
 Renshaw cell rat spinal cord light microscopic study J. Physiol 515 787–797 1999 
	 49 	  E. J. Geiman M. C. Knox F. J. Alvarez postnatal maturation gephyrin/glycine receptor 
 cluster develop renshaw cell J. Comp neurol 426 130–142 2000 
	 50 	  Q. Chang L. J. Martin glycinergic innervation motoneuron deficient amyotrophic 
 lateral sclerosis mouse quantitative confocal analysis J. Pathol 174 574–585 2009 
	  51 	  H. Wootz e. fitzsimons-­ 
 Kantamneni M. Larhammar T. M. Rotterman A. Enjin K. Patra  
 E. Andre B. Van Zundert K. kullander F. J. Alvarez alteration motor neuron-­ 
 renshaw 
 cell circuit sod1(g93a mouse model J. Comp neurol 521 1449–1469 2013 
	 52 	  F. Fornai P. Longone L. Cafaro O. Kastsiuchenka M. Ferrucci M. L. Manca G. Lazzeri  
 A. Spalloni N. Bellio P. Lenzi N. Modugno G. Siciliano C. Isidoro L. Murri S. Ruggieri  
 A. Paparelli lithium delay progression amyotrophic lateral sclerosis proc natl acad 
 Sci u.s.a. 105 2052–2057 2008 
	 53 	  E. S. Deneris O. Hobert Maintenance postmitotic neuronal cell identity nat Neurosci 
 17 899–907 2014 
	 54 	  B. Kadkhodaei A. Alvarsson N. Schintu D. Ramskold N. Volakakis E. Joodmardi  
 T. Yoshitake J. Kehr M. Decressac A. Bjorklund R. Sandberg P. Svenningsson  
 T. Perlmann transcription factor nurr1 maintain fiber integrity nuclear-­ 
 encode 
 mitochondrial gene expression dopamine neuron proc natl acad Sci u.s.a. 110 
 2360–2365 2013 
	 55 	  N. N. Song J. B. Xiu Y. Huang J. Y. Chen L. Zhang L. Gutknecht K. P. Lesch H. Li  
 Y. Q. Ding adult raphe-­ 
 specific deletion lmx1b lead central serotonin deficiency 
 plos 6 e15998 2011 
	 56 	  C. Liu T. Maejima S. C. Wyler G. Casadesus S. Herlitze E. S. Deneris pet-­ 
 1 require 
 different stage life regulate serotonergic function nat Neurosci 13 
 1190–1198 2010 
	 57 	  M. Leboeuf S. e. vargas-­ 
 Abonce E. peze-­ 
 Hedsieck E. Dupont L. jimenez-­ 
 Alonso  
 K. L. Moya A. Prochiantz engrailed-­ 
 1 transcription factor paracrine neurotrophic 
 activity adult spinal α-­ 
 motoneuron embo Rep. 24 e56525 2023 
	 58 	  m. A. Fischler R. C. Bolles random sample consensus commun acm 24 381–395 
 1981 
	 59 	  J. Cohen Statistical Power Analysis Behavioral Sciences Lawrence Erlbaum 
 Associates ed 2 1988 
 acknowledgment acknowledge Department Experimental Medicine 
 University copenhagen especially A. S. Laugesen Core Facility integrated 
 Microscopy Faculty Health Medical Sciences University Copenhagen thank I. 
 vesth-­ 
 Hansen M. Bjerre technical assistance N. Meola S. Wrobel acd bio 
 biotechne technical support discussion funding work support 
 Lundbeck Foundation r346-­ 
 2020-­ 
 2025 R250-­ 
 2017-­ 
 586 I.A. louis-­ 
 Hansen Foundation 
 21-­ 
 2b-­ 
 9477/l102 I.A. Læge Sofus Carl Emil Friis og hustru Olga Doris Friis Foundation 
 1218471001 I.A. Novo Nordisk Laureate Program nnf15oc0014186 O.K. 
 Lundbeck Foundation r345-­ 
 2020-­ 
 1769 O.K. louis-­ 
 Hansen foundation 18-­ 
 2b-­ 
 3570 
 R.M.R. Faculty Health Medical Sciences University copenhagen O.K. 
 I.A. School psychology Neuroscience University St Andrews I.A. 
 Author contribution conceptualization I.A. O.K. r.m.-­ 
 R. Methodology I.A. R.M.-­ 
 R. 
 R.S. p.h.-­ 
 V. J.M.K. Investigation I.A. R.M.-­ 
 R. R.S. d.b.a. S.K.S. Supervision I.A. 
 O.K. writing original draft I.A. O.K. r.m.-­ 
 R. Competing interest ACD bio 
 cartana support study in-­ 
 kind contribution author declare 
 compete interest datum material availability datum support 
 finding study available University St Andrews Research Portal 
 link https://doi.org/10.17630/6985fab0-­ 
 c649-­ 
 4e71-­ 
 9592-­ 
 dbda527040ec code 
 analyze datum available Zenodo https://zenodo.org/doi/10.5281/zenodo.10600982 
 https://zenodo.org/doi/10.5281/zenodo.10600964 datum need evaluate 
 conclusion paper present paper and/or Supplementary Materials detail 
   situ sequencing hiplexup probe provide 10x Genomics 
 acd bio pende scientific review complete material transfer agreement request 
 probe sequence detail submit 10x Genomics Inc. Delaware 
 corporation have principal place business 6230 Stoneridge Mall Road Pleasanton 
 94588 USA advanced Cell Diagnostics Inc. located 7707 Gateway Blvd Newark 
 94560 USA 
 submit 22 August 2023 
 Accepted 29 April 2024 
 publish 31 2024 
 10.1126/sciadv.adk3229 
 Downloaded https://www.science.org June 01 2024 
